Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11524 posts found.

shutterstock_138095450

CureTech reclaims rare disease drug from Pfizer for $20 million

October 2, 2017 Sales and Marketing Clal Biotechnology, CureTech, Medivation, Pfizer, pharma, pharmaceutical

CureTech, a biotech firm owned by Clal Biotechnology Industries, is set to reclaim a drug it sold more than two …
News
ablynx_building_web

Ablynx posts strong data on key drug, looks set for approval

October 2, 2017 Research and Development, Sales and Marketing Ablynx, biotech, drugs, pharma, pharmaceutical

In a major success for the European biotech industry, Ablynx has revealed that it had met the primary and secondary …
News
lilly_logo_2

Lilly reveals major senior leadership reshuffle

October 2, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Eli Lilly, biotech, drugs, pharma, pharmaceutical

Eli Lilly revealed on 29 September that it would promote four staff members to senior staff positions, and two senior …
Appointment
merck_incweb

MSD pulls out of hep C space to Gilead’s relief

October 2, 2017 Sales and Marketing MSD, biotech, drugs, hepatitis C, pharma, pharmaceutical

MSD, known as Merck in North America, has announced that it will curtail its attempts to make an impact in …
News
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

September 29, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Allergan, EMA, FDA, HIV, J&J, JJ, Kevzara, Mylan, NICE, Sanofi, nash, top ten

It’s Friday, and it’s time for another round up of the most popular articles on pharmafile.com over the last seven …
News
lilly2_web

Lilly receives FDA breast cancer pill approval, doubts remain

September 29, 2017 Medical Communications, Sales and Marketing Eli Lilly, Verzenio, biotech, drugs, pharma, pharmaceutical

Eli Lilly has received an important approval for its breast cancer treatment, Verzenio. The drug will be the third to …
News
humira_abbott_

Five more biosimilar-free years for AbbVie’s megablockbuster

September 28, 2017 Medical Communications, Sales and Marketing AbbVie, Amgen, Amjevita, Humira, biotech, drugs, pharma, pharmaceutical

Humira is the key drug for AbbVie, and one the company hopes it will be able to push into the …
News
hassan_fahmi

Novo Nordisk Egypt promotes new General Manager

September 28, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Novo Nordisk, biotech, drugs, pharma, pharmaceutical

Novo Nordisk Egypt has promoted Hassan Fahmi to become its new General Manager for operations within the company. Fahmi arrived …
Appointment
shutterstock_114306559

Could the new EU Medical Devices Regulation put the UK MedTech industry in peril?

September 28, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing life sciences, medical devices, medical technology, medtech, medtech regulation, pharma, pharmaceutical

Gill Jennings and Every’s Fiona Stevens discusses recent developments in medical devices regulation and the subsequent impact on IP and …
Feature
roche

Roche chalks up Swiss approval for multiple sclerosis drug Ocrevus

September 28, 2017 Sales and Marketing Ocrevus, Roche, multiple sclerosis, pharma, pharmaceutical

Roche has announced that its drug Ocrevus (ocrelizumab) has received marketing approval in Switzerland for the treatment of active relapsing …
News
sanofi_regeneron

Sanofi and Regeneron’s projected blockbuster gains EU approval

September 28, 2017 Sales and Marketing Dupixent, Regeneron, Sanofi, biotech, drugs, pharma, pharmaceutical

Sanofi and Regeneron have big hopes for their treatment Dupixent, and it has taken an important step towards reaching the …
News
roche

Roche’s Tecentriq scores approvals in metastatic lung and bladder cancer

September 27, 2017 Research and Development, Sales and Marketing Cancer, EMA, EU, European Commission, Roche, bladder cancer, immunotherapy, lung cancer, pharma, tecentriq

It’s good news for Roche as the company’s immunotherapy drug Tecentriq secures approval from the European Commission to be used …
News
online_version

New CMO hops onto Bicycle Therapeutics

September 26, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, Bicycle Therapeutics, GSK, Pfizer, biotech, drugs, pharma, pharmaceutical

Bicycle Therapeutics has moved to appoint industry veteran, Maria Koehler, to the position of Chief Medical Officer at the company. …
Appointment
tessa_hilado-web-aug2017-allergan

Allergan’s Executive VP and Chief Financial Officer steps down

September 26, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Allergan, appointment

Allergan has announced that its Executive Vice President and Chief Financial Officer Tessa Hilado intends to step down from her …
Appointment

FDA pointedly rejects Intellipharma’s opioid painkiller

September 26, 2017 Manufacturing and Production, Sales and Marketing FDA, Intellipharma, biotech, drugs, pharma, pharmaceutical

The FDA has been very public in its stance that it will look to gain the upper hand in bringing …
News
The Gateway to Local Adoption Series

Latest content

Thermo Fisher opens new distribution centre in Ireland

March 12, 2026

Altimetrik appoints Dhirendra Nath as Chief Human Resources Officer

March 12, 2026

Kindeva appoints Mike Cowhig as Chief Legal Officer

March 11, 2026

DiaMedica gets regulatory clearance from Health Canada for phase 2 preeclampsia study

March 11, 2026

Abselion establishes a US subsidiary in Massachusetts 

March 10, 2026